Results 211 to 220 of about 20,408 (237)
Some of the next articles are maybe not open access.
Morphological changes in the testis induced by diethylcarbamazine
Reproductive Toxicology, 2006Diethylcarbamazine (DEC) had been proved to be highly effective against lymphatic filariasis, however its effect on vertebrate cells remains uncertain. After 12 days treatment with DEC, most of the Leydig cells were hypertrophied with several lipid droplets, and others had no nucleus and presented characteristic steatosis features.
Valdemiro Amaro da Silva Junior+3 more
openaire +3 more sources
Genotoxic potential of diethylcarbamazine, an antifilarial drug
Toxicology Letters, 1988The mutagenic potential of diethylcarbamazine (DEC) was evaluated by metaphase chromosome analysis and the micronucleus test in bone marrow cells of mice. Both assay systems revealed clastogenicity, although not severe. The time-response study of metaphase chromosomes exhibited an early effect; at 72 h post-treatment the effect came down to the control
B. Roy, R.K. Das
openaire +3 more sources
Comparison of Ivermectin and Diethylcarbamazine in the Treatment of Onchocerciasis
New England Journal of Medicine, 1985We compared ivermectin with diethylcarbamazine for the treatment of onchocerciasis in a double-blind, placebo-controlled trial. Thirty men with moderate to heavy infection and ocular involvement were randomly assigned to receive ivermectin in a single oral dose (200 micrograms per kilogram of body weight), diethylcarbamazine daily for eight days, or ...
Bruce M. Greene+14 more
openaire +3 more sources
Immunoadjuvant effect of diethylcarbamazine in experimental filariasis
International Immunopharmacology, 2015Lymphatic filariasis caused by tissue dwelling nematodes is endemic in 73 countries and drugs have been administered to control or stop the infection. Resurgence of the infection after mass drug administration necessitates the study of several parasite antigens or adjuvants for vaccine developments. In this study, diethylcarbamazine (DEC) was evaluated
Kaliraj Perumal+4 more
openaire +2 more sources
Platelets mediate the action of diethylcarbamazine on microfilariae
Nature, 1987More than 400 million people in the world are infected by filarial parasites leading to a wide range of pathologies. Although introduced in 1947, the mainstay of the therapy and control of the filariases is diethylcarbamazine (N,N-diethyl-4-methyl-1-piperazine carboxamide; DEC), the mode of action of which still remains unknown despite widespread use ...
Henri Taelman+7 more
openaire +3 more sources
Diethylcarbamazine in ascariasis [PDF]
N. G. Mojumdar, B. Biswas
openaire +2 more sources
In vivo suppression of delayed hypersensitivity by thiabendazole and diethylcarbamazine
Immunopharmacology, 1981Several anthelminthic agents, such as niridazole and metronidazole, have been demonstrated to have striking effects on the immune system, apparently independent of their antiparasitic activities. In the present study, we have examined the effect of thiabendazole and diethylcarbamazine on two parameters of delayed hypersensitivity, lung granuloma ...
Erik L. Hewlett+3 more
openaire +3 more sources
Diethylcarbamazine Salt in the Control of Lymphatic Filariasis
The American Journal of Tropical Medicine and Hygiene, 1994Where lymphatic filariasis has diminished since about the 1950s, it has most frequently, though not always, been a direct result of chemotherapeutic intervention against the parasite. Diethylcarbamazine (DEC), a well-established drug, has been the single agent of chemotherapeutic control and has been successful in a wide variety of regimens. This paper
openaire +3 more sources
Diethylcarbamazine and New Compounds for the Treatment of Filariasis
1979Publisher Summary This chapter discusses the diethylcarbamatine and new compounds for the treatment of filariasis. Diethylcarbamazine is 1-diethylcarbamyl-4-methylpiperazine; it is also known as Hetrazan, Banocide, Notezine, Caricide, Carbilazine, Supatonin, and R.P. 3799.
openaire +3 more sources
The treatment of ascariasis and ancylostomiasis with hetrazan (diethylcarbamazine)
Transactions of the Royal Society of Tropical Medicine and Hygiene, 1954Abstract The encouraging results obtained by Hewitt et al. (1948) in the treatment of canine ascariasis with hetrazan formed the basis of its trial in human beings. Oliver Gonzales et al. (1949) treated six patients with favourable results giving 2 mg. per kg. body weight three times daily for 24 hours, and followed 8 hours later by a purge.
openaire +3 more sources